NEURONEWS Prawdziwa struktura α-synukleiny

• Authors: Karol Jastrzębski
• Languages of publication: PL
• Journal: Aktualności Neurologiczne
• Year: 2016
• Volume: 16
• Issue: 1
• Pages: 53-54

Contributors

author

Karol Jastrzębski

References

• Alderson TR, Markley JL: Biophysical characterization of α-synuclein and its controversial structure. Intrinsically Disord Proteins 2013; 1: 18–39.
• Alemi M, Gaiteiro C, Ribeiro CA et al.: Transthyretin participates in beta-amyloid transport from the brain to the liver- involvement of the low-density lipoprotein receptor-related protein 1? Sci Rep 2016; 6: 20164.
• Auriel E, Charidimou A, Gurol ME et al.: Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol 2016; 73: 197–202.
• Bales KR, O’Neill SM, Pozdnyakov N et al.: Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity. Brain 2016; 139: 563–577.
• Faure J, Lachenal G, Court M et al.: Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006; 31: 642–648.
• Fitzner D, Schnaars M, van Rossum D et al.: Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 2011; 124: 447–458.
• Mezey E, Dehejia AM, Harta G et al.: Alpha synuclein is present in Lewy bodies in sporadic Parkinson’s disease. Mol Psychiatry 1998; 3: 493–499.
• Spillantini MG, Schmidt ML, Lee VM et al.: Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839–840.
• Stuendl A, Kunadt M, Kruse N et al.: Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies. Brain 2016; 139: 481–494.
• Tanzi RE, Moir RD, Wagner SL: Clearance of Alzheimer’s Aβ peptide: the many roads to perdition. Neuron 2004; 43: 605–608.
• Theillet FX, Binolfi A, Bekei B et al.: Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 2016; 530: 45–50.

• Document Type: minireview